iPhone 7 and diabetes

iPhone 7 and diabetes

Tomorrow in what’s likely to be a way cool whiz bang event Apple will unveil their latest iPhone. Based on all the reports we have read this newest version will only be marginally better than previous versions. Not all that surprising given this is an already way cool whiz bang device and Apple is reaching the point of diminishing returns when it comes to making improvements. In many respects this is not unlike what’s happened in the conventional glucose monitoring market. Listen sometimes devices reach a point where there just isn’t much more that can be done to make them better.

Recently we’ve been writing about Apple’s more public statements regarding their move into healthcare. A move which isn’t surprising given what’s going at all their Silicon Valley neighbors. Nor is it any surprise that diabetes will be a major focus for the company. It’s no longer a question of if a patient’s smartphone will become the epicenter of their diabetes management but when this happen.

The day when patients are prescribed a diabetes management system, something we have been predicting for years, is within sight. And who better to develop and manage these systems then our friends in Silicon Valley. Companies who as we have said before don’t need to be in diabetes but want to be in diabetes. Companies which have the human and financial resources to turn a vision into reality. Companies which are not shackled to the past and can start with a clean slate.

Frankly for the first time in many years Diabetic Investor is truly excited about the future of diabetes management. This move by our friends in the Valley not gives us hope but true optimism. It also sets the stage from real wackiness. While our Valley friends have many positive attributes they cannot proceed down this path alone. The smart companies understand that while the old guard has seen better days they are needed. They bring with them not only diabetes experience but valuable pieces of the puzzle.

Gazing into the crystal ball known as the future we can see some very interesting alliances. As Momma Kliff was fond of saying; “Money may buy lots of things but it doesn’t buy happiness.” This is perhaps the most misunderstood aspect of the Valley’s move into diabetes. Let’s be honest any company with gobs of money can go out an acquire all the pieces of the puzzle. This is the easy part.

Yet as we have said about the insulin pump market, building an insulin pump is the easy part effectively running an insulin pump company is where the rubber meets the road. The same is true for building and managing a diabetes management system. This requires a delicate balancing act bringing two divergent worlds together. Simply put for this to work the old guard and new visionaries must find a way to work together, to learn from each other and not compete with each other. When this happens it won’t just be exciting but amazing.

The question now becomes who in the Valley is truly visionary and this does not just mean putting their money where their vision is. Who in the Valley will walk this tightrope between old and new. Who in the Valley will balance the needs of today against their vision of the future. For as much as everyone wants to get to the future the needs of today cannot and should not be ignored. As Momma Kliff used to say; “This is like running a marathon. You don’t just get up one morning and run 26.3 miles. You start by running 1 mile and working your way to 26.3.”

Anyone who has done such a thing understands the range of challenges this brings. The long lonely hours of training. The pain the body takes from the constant pounding. The commitment this takes. Yet they also understand that emotional unexplainable high when the finish line is within sight and that dream which started months earlier is about to become a reality.

Well my friends when it comes to this wacky world the finish line is not yet within sight, but it is becoming more real with each mile run.